article thumbnail

Beating the Big C

Pharmaceutical Technology

” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” ” Supply and revenue Cancer drugs can plug revenue gaps created by loss of patents in other areas, as Pfizer hopes to do when competition for its cholesterol fighter Lipitor opens up in two years’ time.